Open AccessJournal Article
[Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy].
Pal'tsev Ai,Sharapov,Gorbunova En,Khomchenko Tn,Kurganova,Soldatova Gs,Eremina Aa,Nikolaev IuA +7 more
7
TL;DR: The conducted investigation have shown high efficiency of the drug at combined treatment of a patient and influence of Metadoxil in patients with NSH and NASH.
read more
Abstract: Non-alcoholic fatty liver disease, including non-alcoholic steatohepatosis (NSH) and non-alcoholic steatohepatitis (NASH) is considered to be a wide spread disease. Such reasons as metabolic, toxic, infections, alimentary and cryptogenic cause this disease. Pathogenesis of the disease is complex. If the necessary medical preventive measures are absent the disease develops as follows, first steatosis, then steatohepatitis, fibrosis, liver cirrhosis, hepatocarcinoma. The aim of the investigation was to study influence of Metadoxil in patients with NSH and NASH. The conducted investigation have shown high efficiency of the drug at combined treatment of a patient.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
A method for decreasing symptoms of alcohol consumption
Gur Megiddo,Dalia Megiddo,Rina Yamin,Yaron Ilan,Shimon Amselem +4 more
- 03 Jul 2008
TL;DR: In this article, the authors present methods and compositions of metadoxine and physiologically compatible active derivatives thereof, and their use for decreasing symptoms of alcohol consumption as well as in the prevention of consumption related symptoms in subjects in need thereof.
13
Patent
Substituted pyridoxine-lactam carboxylate salts
Rina Yamin,Dalia Megiddo +1 more
- 29 Jul 2009
TL;DR: The present paper as discussed by the authors provides salt adducts comprising at least one positively charged moiety being a pyridoxine or a derivative thereof and at least a carboxylated 5- to 7-membered lactam ring, optionally additionally substituted, methods of their preparation, and pharmaceutical compositions and medicaments comprising them.
8
Patent
Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
Frederick Van Gulik,Rao Yamsani Madhusudan,Shankar Bodapunti Prabha +2 more
- 22 Jan 2013
TL;DR: The use of metadoxine in the prevention and in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH, in the improvement of the survival rate of patients with Severe Alcoholic Hepatitis and to a new extended release pharmaceutical formulations comprising metadioxine as mentioned in this paper.
1
Modern approaches to pharmacotherapy of non-alcoholic fatty liver disease
Maksim Leonidovich Maksimov,Albina Airatovna Zvegintseva,Tatyana Sergeevna Shindina +2 more
- 01 Feb 2021
TL;DR: The main directions in the pharmacological treatment of NAFLD are the prescription of drugs that reduce body weight, increase the of tissues to insulin, affect oxidative stress, normalize the levels of lipids and blood transaminases, and correct intestinal microflora.
Patent
Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
Rina Yamin,Dalia Megiddo,Yaron Ilan +2 more
- 03 Jul 2012
TL;DR: In this paper, the use of a salt adduct comprising at least one positively charged moiety being a pyridoxine or a derivative thereof for the preparation of medicaments for the improvement of cognitive functions in a healthy subject.